Treace(TMCI) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Treace Medical Concepts Reports Second Quarter 2024 Financial Results PONTE VEDRA, Fla. – August 6, 2024 – Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights • Revenue of $44.5 million in ...